Barbara Klencke - 01 Nov 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Barbara Klencke
Issuer symbol
EFTR
Transactions as of
01 Nov 2021
Transactions value $
$0
Form type
4
Filing time
02 Nov 2021, 19:10:21 UTC
Next filing
28 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +40,000 $0 40,000 01 Nov 2021 Common Stock 40,000 $10.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on November 1, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date.